JP2025508792A5 - - Google Patents

Info

Publication number
JP2025508792A5
JP2025508792A5 JP2024549554A JP2024549554A JP2025508792A5 JP 2025508792 A5 JP2025508792 A5 JP 2025508792A5 JP 2024549554 A JP2024549554 A JP 2024549554A JP 2024549554 A JP2024549554 A JP 2024549554A JP 2025508792 A5 JP2025508792 A5 JP 2025508792A5
Authority
JP
Japan
Prior art keywords
solvates
hydrates
well
salt
ray powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508792A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/077409 external-priority patent/WO2023160542A1/zh
Publication of JP2025508792A publication Critical patent/JP2025508792A/ja
Publication of JP2025508792A5 publication Critical patent/JP2025508792A5/ja
Pending legal-status Critical Current

Links

JP2024549554A 2022-02-22 2023-02-21 ジペプチジルペプチダーゼ阻害化合物の塩及び結晶形態 Pending JP2025508792A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210160862 2022-02-22
CN202210160862.5 2022-02-22
PCT/CN2023/077409 WO2023160542A1 (zh) 2022-02-22 2023-02-21 二肽基肽酶抑制剂化合物的盐及晶型

Publications (2)

Publication Number Publication Date
JP2025508792A JP2025508792A (ja) 2025-04-10
JP2025508792A5 true JP2025508792A5 (cg-RX-API-DMAC10.html) 2026-02-27

Family

ID=87764787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549554A Pending JP2025508792A (ja) 2022-02-22 2023-02-21 ジペプチジルペプチダーゼ阻害化合物の塩及び結晶形態

Country Status (13)

Country Link
US (1) US20250188067A1 (cg-RX-API-DMAC10.html)
EP (1) EP4484414A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025508792A (cg-RX-API-DMAC10.html)
KR (1) KR20240153351A (cg-RX-API-DMAC10.html)
CN (1) CN118660873A (cg-RX-API-DMAC10.html)
AU (1) AU2023225835A1 (cg-RX-API-DMAC10.html)
CA (1) CA3243683A1 (cg-RX-API-DMAC10.html)
CL (1) CL2024002490A1 (cg-RX-API-DMAC10.html)
IL (1) IL314852A (cg-RX-API-DMAC10.html)
MX (1) MX2024010180A (cg-RX-API-DMAC10.html)
TW (1) TW202342466A (cg-RX-API-DMAC10.html)
WO (1) WO2023160542A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202407225B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025506307A (ja) * 2022-02-22 2025-03-07 ハイスコ ファーマスーティカル プライベート リミテッド 含窒素複素環化合物の調製方法
JP2026503035A (ja) 2023-01-06 2026-01-27 インスメッド インコーポレイテッド 新規な可逆性dpp1阻害剤及びその用途
WO2025162472A1 (en) 2024-01-31 2025-08-07 Insmed Incorporated Linear dipeptidyl peptidase 1 inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902181B2 (en) * 2007-12-12 2011-03-08 Astrazeneca Ab Compounds 010
NO2699580T3 (cg-RX-API-DMAC10.html) * 2014-01-24 2018-02-24
PL4129989T3 (pl) * 2020-08-26 2025-02-24 Haisco Pharmaceuticals Pte. Ltd. Pochodna nitrilu działająca jako inhibitor dipeptydylopeptydazy 1 i jej zastosowanie
CN114106005B (zh) * 2020-08-26 2025-08-01 西藏海思科制药有限公司 一种作为二肽基肽酶1抑制剂的腈衍生物及其用途
CN114591315A (zh) * 2020-12-04 2022-06-07 瑞石生物医药有限公司 一种组织蛋白酶c小分子抑制剂
WO2022166721A1 (zh) * 2021-02-05 2022-08-11 南京明德新药研发有限公司 含1,4-氧杂氮杂环庚烷的并环类衍生物

Similar Documents

Publication Publication Date Title
JPWO2022138988A5 (cg-RX-API-DMAC10.html)
JP2007500233A5 (cg-RX-API-DMAC10.html)
JP2023036708A5 (cg-RX-API-DMAC10.html)
JP2026048795A (ja) Lnp023の結晶形態
CN105218386A (zh) 3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚的盐或共晶体
PT1461306E (pt) Compostos de amónio quaternário
PT1353919E (pt) Novos derivados de quinuclidina e composições medicinais contendo os mesmos
JP2024547113A5 (cg-RX-API-DMAC10.html)
JP2022507251A5 (cg-RX-API-DMAC10.html)
JP2024505063A5 (cg-RX-API-DMAC10.html)
TW200817398A (en) Quinuclidine derivatives as M3 antagonists
JP2022511800A5 (cg-RX-API-DMAC10.html)
TW202200594A (zh) 一種glp-1受體激動劑的晶型a及其製備方法
JP2022534788A5 (cg-RX-API-DMAC10.html)
WO2025002355A9 (zh) 一种jak2抑制剂的晶型及制备方法
JP2024517431A5 (cg-RX-API-DMAC10.html)
JP2025516683A5 (cg-RX-API-DMAC10.html)
JP2024514090A5 (cg-RX-API-DMAC10.html)
JP2025502300A5 (cg-RX-API-DMAC10.html)
TWI834634B (zh) 醫藥化合物、其鹽類、其製劑及其等之製備和使用之方法
US20100266679A1 (en) Crystalline modifications of n-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (l)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof
CN110087729A (zh) 一类具有季铵盐结构的双功能化合物
JP2023521411A5 (cg-RX-API-DMAC10.html)
JP2024001040A5 (cg-RX-API-DMAC10.html)
JP2013516475A5 (cg-RX-API-DMAC10.html)